Lumbard & Kellner’s Pfizer PFE Stock Holding History

Lumbard & Kellner’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-108,528	Closed	-$2.75M	–	94
2025 Q1	$2.75M	Sell	108,528 -3,895	-3%	-$102K	1.21%	35
2024 Q4	$2.98M	Sell	112,423 -5,212	-4%	-$141K	1.28%	34
2024 Q3	$3.4M	Buy	117,635 +3,734	+3%	+$109K	1.5%	28
2024 Q2	$3.19M	Buy	113,901 +8,454	+8%	+$233K	1.51%	29
2024 Q1	$2.93M	Buy	+105,447	New	+$2.93M	1.42%	31
2022 Q2	–	Sell	-1,738	Closed	-$90K	–	88
2022 Q1	$90K	Sell	1,738 -2,000	-54%	-$104K	0.04%	88
2021 Q4	$200K	Buy	+3,738	New	+$185K	0.08%	88
2015 Q1	–	Sell	-107,369	Closed	-$3.17M	–	91
2014 Q4	$3.17M	Hold	107,369	–	–	2.24%	16
2014 Q3	$3.01M	Buy	107,369 +2,293	+2%	+$64.4K	2.13%	13
2014 Q2	$2.96M	Buy	105,076 +1,702	+2%	+$48.5K	2.11%	15
2014 Q1	$3M	Hold	103,374	–	–	2.57%	12
2013 Q4	$3M	Buy	+103,374	New	+$3.01M	2.57%	12

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lumbard & Kellner's PFE Position: Q2 2025 in Review

Lumbard & Kellner sold out of Pfizer (PFE) in Q2 2025, closing a stake of 108,528 shares — an estimated $2.75M sold.

Lumbard & Kellner first reported a position in PFE in Q4 2013 and held it in 12 quarters. The position peaked at $3.4M in Q3 2024. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Lumbard & Kellner reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Lumbard & Kellner sold 108,528 Pfizer shares in Q2 2025, an estimated $2.75M.
Lumbard & Kellner first reported a position in Pfizer in Q4 2013 and held it in 12 quarters.
Lumbard & Kellner's Pfizer position peaked at $3.4M in Q3 2024.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Lumbard & Kellner's 13F filing for Q2 2025, filed 13 Aug 2025.